Human filarial Wolbachia lipopeptide directly activates human neutrophils in vitro

Parasite Immunology

Volumn 36, Issue 10, 2014, Pages 494-502

  Tamarozzi, F ^a,c   Wright, H L ^b   Johnston, K L ^a   Edwards, S W ^b   Turner, J D ^a   Taylor, Mark J ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Filariasis; Human neutrophils activation; Onchocerca volvulus; River blindness; Wolbachia; Wolbachia lipoproteins

Indexed keywords

BACTERIAL PROTEIN; CELL ADHESION MOLECULE; FILARIAL WOLBACHIA LIPOPEPTIDE; INTERLEUKIN 8; L SELECTIN; LIPOPEPTIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL STRUCTURE; CELL SURVIVAL; CHEMOTAXIS; COMPARATIVE STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; LEUKOCYTE ACTIVATION; NONHUMAN; NORMAL HUMAN; ONCHOCERCIASIS; PATTERN RECOGNITION; PROTEIN PROTEIN INTERACTION; RESPIRATORY BURST; UPREGULATION; WOLBACHIA; ANIMAL; IMMUNOLOGY; MICROBIOLOGY; NEUTROPHIL; ONCHOCERCA VOLVULUS; PARASITOLOGY; PATHOLOGY;

ANIMALS; APOPTOSIS; CHEMOTAXIS; HUMANS; INTERLEUKIN-8; LIPOPEPTIDES; NEUTROPHILS; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS, OCULAR; RESPIRATORY BURST; WOLBACHIA;

EID: 84908306077     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12122     Document Type: Article

References (41)

1. Basanez MG, Pion SD, Churcher TS, Breitling LP, Little MP & Boussinesq M. River blindness: a success story under threat? PLoS Med 2006; 3: e371.
2. WHO. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. World Health Organ Tech Rep Ser 1995; 852: 1-104.
3. Tamarozzi F, Halliday A, Gentil K, Hoerauf A, Pearlman E & Taylor MJ. Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment. Clin Microbiol Rev 2011; 24: 459-468.
4. Gillette-Ferguson I, Hise AG, McGarry HF, et al. Wolbachia-induced neutrophil activation in a mouse model of ocular onchocerciasis (river blindness). Infect Immun 2004; 72: 5687-5692.
5. Pearlman E, Garhart CA, Grand DJ, Diaconu E, Strine ER & Hall LR. Temporal recruitment of neutrophils and eosinophils to the skin in a murine model for onchocercal dermatitis. Am J Trop Med Hyg 1999; 61: 14-18.
6. Pearlman E, Hall LR, Higgins AW, et al. The role of eosinophils and neutrophils in helminth-induced keratitis. Invest Ophthalmol Vis Sci 1998; 39: 1176-1182.
7. Saint Andre A, Blackwell NM, Hall LR, et al. The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness. Science 2002; 295: 1892-1895.
8. Gillette-Ferguson I, Daehnel K, Hise AG, et al. Toll-like receptor 2 regulates CXC chemokine production and neutrophil recruitment to the cornea in Onchocerca volvulus/Wolbachia-induced keratitis. Infect Immun 2007; 75: 5908-5915.
9. Gillette-Ferguson I, Hise AG, Sun Y, et al. Wolbachia- and Onchocerca volvulus-induced keratitis (river blindness) is dependent on myeloid differentiation factor 88. Infect Immun 2006; 74: 2442-2445.
10. Gutierrez-Pena EJ, Knab J & Buttner DW. Neutrophil granule proteins: evidence for the participation in the host reaction to skin microfilariae of Onchocerca volvulus after diethylcarbamazine administration. Parasitology 1996; 113(Pt 4): 403-414.
11. Brattig NW, Buttner DW & Hoerauf A. Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria. Microbes Infect 2001; 3: 439-446.
12. Brattig NW. Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria. Microbes Infect 2004; 6: 113-128.
13. Nfon CK, Makepeace BL, Njongmeta LM, Tanya VN, Bain O & Trees AJ. Eosinophils contribute to killing of adult Onchocerca ochengi within onchocercomata following elimination of Wolbachia. Microbes Infect 2006; 8: 2698-2705.
14. Hansen RD, Trees AJ, Bah GS, et al. A worms best friend: recruitment of neutrophils by Wolbachia confounds eosinophil degranulation against the filarial nematode Onchocerca ochengi. Proc Biol Sci 2011; 278: 2293-2302.
15. Wildenburg G, Plenge-Bonig A, Renz A, Fischer P & Buttner DW. Distribution of mast cells and their correlation with inflammatory cells around Onchocerca gutturosa, O. tarsicola, O. ochengi, and O. flexuosa. Parasitol Res 1997; 83: 109-120.
16. Cross HF, Haarbrink M, Egerton G, Yazdanbakhsh M & Taylor MJ. Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood. Lancet 2001; 358: 1873-1875.
17. Keiser PB, Reynolds SM, Awadzi K, Ottesen EA, Taylor MJ & Nutman TB. Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. J Infect Dis 2002; 185: 805-811.
18. Turner JD, Mand S, Debrah AY, et al. A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. Clin Infect Dis 2006; 42: 1081-1089.
19. Njoo FL, Hack CE, Oosting J, Stilma JS & Kijlstra A. Neutrophil activation in ivermectin- treated onchocerciasis patients. Clin Exp Immunol 1993; 94: 330-333.
20. Turner JD, Langley RS, Johnston KL, et al. Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis. J Biol Chem 2009; 284: 22364- 22378.
21. Johnston KL, Wu B, Guimaraes A, Ford L, Slatko BE & Taylor MJ. Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes. Parasit Vectors 2010; 3: 99.
22. Bennuru S, Meng Z, Ribeiro JM, et al. Stage-specific proteomic expression patterns of the human filarial parasite Brugia malayi and its endosymbiont Wolbachia. Proc Natl Acad Sci USA 2011; 108: 9649- 9654.
23. Bennuru S, Semnani R, Meng Z, Ribeiro JM, Veenstra TD & Nutman TB. Brugia malayi excreted/secreted proteins at the host/ parasite interface: stage- and gender-specific proteomic profiling. PLoS Negl Trop Dis 2009; 3: e410.
24. Hayashi F, Means TK & Luster AD. Tolllike receptors stimulate human neutrophil function. Blood 2003; 102: 2660-2669.
25. Neufert C, Pai RK, Noss EH, Berger M, Boom WH & Harding CV. Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation. J Immunol 2001; 167: 1542-1549.
26. Sabroe I, Prince LR, Jones EC, et al. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 2003; 170: 5268-5275.
27. Seifert R, Schultz G, Richter-Freund M, et al. Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser- (Lys)4. Involvement of guanine-nucleotidebinding proteins and synergism with chemotactic peptides. Biochem J 1990; 267: 795-802.
28. Soler-Rodriguez AM, Zhang H, Lichenstein HS, et al. Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: differential requirements for serum and CD14. J Immunol 2000; 164: 2674-2683.
29. Wilde I, Lotz S, Engelmann D, et al. Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes. Med Microbiol Immunol 2007; 196: 61-71.
30. Sabroe I, Jones EC, Usher LR, Whyte MK & Dower SK. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 2002; 168: 4701-4710.
31. Francois S, El Benna J, Dang PM, Pedruzzi E, Gougerot-Pocidalo MA & Elbim C. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J Immunol 2005; 174: 3633-3642.
32. Power CP, Wang JH, Manning B, et al. Bacterial lipoprotein delays apoptosis in human neutrophils through inhibition of caspase-3 activity: regulatory roles for CD14 and TLR-2. J Immunol 2004; 173: 5229-5237.
33. Prince LR, Allen L, Jones EC, et al. The role of interleukin-1beta in direct and tolllike receptor 4-mediated neutrophil activation and survival. Am J Pathol 2004; 165: 1819-1826.
34. Gallin MY, Jacobi AB, Buttner DW, Schonberger O, Marti T & Erttmann KD. Human autoantibody to defensin: disease association with hyperreactive onchocerciasis (sowda). J Exp Med 1995; 182: 41-47.
35. Edgeworth JD, Abiose A & Jones BR. An immunohistochemical analysis of onchocercal nodules: evidence for an interaction between macrophage MRP8/MRP14 and adult Onchocerca volvulus. Clin Exp Immunol 1993; 92: 84-92.
36. Gottsch JD, Eisinger SW, Liu SH & Scott AL. Calgranulin C has filariacidal and filariastatic activity. Infect Immun 1999; 67: 6631- 6636.
37. Zabucchi G, Menegazzi R, Cramer R, Nardon E & Patriarca P. Mutual influence between eosinophil peroxidase (EPO) and neutrophils: neutrophils reversibly inhibit EPO enzymatic activity and EPO increases neutrophil adhesiveness. Immunology 1990; 69: 580-587.
38. Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007; 176: 231-241.
39. Guimaraes-Costa AB, Nascimento MT, Wardini AB, Pinto-da-Silva LH & Saraiva EM. ETosis: a microbicidal mechanism beyond cell death. J Parasitol Res 2012; 2012: 929743.
40. Mantovani A, Cassatella MA, Costantini C & Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 2011; 11: 519-531.
41. Abi Abdallah DS, Egan CE, Butcher BA & Denkers EY. Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation. Int Immunol 2011; 23: 317-326.